<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>4D Molecular Therapeutics, Inc. (FDMT) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/fdmt/filings</link>
    <description>Latest company filings for 4D Molecular Therapeutics, Inc. (FDMT) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 22:59:00 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/fdmt/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000134682426000143/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001346824-26-000143</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000092189526001391/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000921895-26-001391</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/999999999526001626/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-001626</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a EFFECT (EFFECT) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000009375126000197/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000093751-26-000197</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Securities registration (S-3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526212323/d298087ds3.htm</link>
      <guid isPermaLink="false">0001193125-26-212323</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Securities registration (S-3) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>S-3</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526211939/fdmt-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-211939</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526211904/fdmt-20260507.htm</link>
      <guid isPermaLink="false">0001193125-26-211904</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000114036126017435/ny20063669x3_ars.pdf</link>
      <guid isPermaLink="false">0001140361-26-017435</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000114036126017430/ny20063669x2_defa14a.htm</link>
      <guid isPermaLink="false">0001140361-26-017430</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm</link>
      <guid isPermaLink="false">0001140361-26-017427</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526131739/fdmt-20260325.htm</link>
      <guid isPermaLink="false">0001193125-26-131739</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-30.]]></description>
      <pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526129156/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-129156</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526129155/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-129155</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526129154/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-129154</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000010290926000363/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000363</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526122341/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-122341</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2026-03-24.]]></description>
      <pubDate>Tue, 24 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526114200/d88128ds8.htm</link>
      <guid isPermaLink="false">0001193125-26-114200</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526114075/fdmt-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-114075</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Annual report (10-K) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526113949/fdmt-20260318.htm</link>
      <guid isPermaLink="false">0001193125-26-113949</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000138832526000011/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001388325-26-000011</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000134682426000029/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001346824-26-000029</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000092189526000459/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000921895-26-000459</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526022559/fdmt-20260122.htm</link>
      <guid isPermaLink="false">0001193125-26-022559</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-26.]]></description>
      <pubDate>Mon, 26 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526006809/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006809</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526006805/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006805</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a New insider ownership (3) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312526005470/fdmt-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-005470</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525331299/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-331299</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-12-23.]]></description>
      <pubDate>Tue, 23 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525326864/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-326864</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a New insider ownership (3) on 2025-12-19.]]></description>
      <pubDate>Fri, 19 Dec 2025 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525326851/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-326851</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-12-19.]]></description>
      <pubDate>Fri, 19 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000195004725010414/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-25-010414</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider sale notice (144) on 2025-12-16.]]></description>
      <pubDate>Tue, 16 Dec 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525320992/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-320992</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-12-16.]]></description>
      <pubDate>Tue, 16 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525315989/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-315989</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-12-11.]]></description>
      <pubDate>Thu, 11 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525315962/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-315962</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a New insider ownership (3) on 2025-12-11.]]></description>
      <pubDate>Thu, 11 Dec 2025 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525314167/fdmt-20251210.htm</link>
      <guid isPermaLink="false">0001193125-25-314167</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2025-12-10.]]></description>
      <pubDate>Wed, 10 Dec 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525288632/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-288632</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-11-19.]]></description>
      <pubDate>Wed, 19 Nov 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000195004725008964/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-25-008964</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider sale notice (144) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525283861/d14139d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-283861</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525273343/fdmt-20250930.htm</link>
      <guid isPermaLink="false">0001193125-25-273343</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Quarterly report (10-Q) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525273340/fdmt-20251110.htm</link>
      <guid isPermaLink="false">0001193125-25-273340</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525272286/d89818d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-272286</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-07.]]></description>
      <pubDate>Fri, 07 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525269700/d52514d424b5.htm</link>
      <guid isPermaLink="false">0001193125-25-269700</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2025-11-06.]]></description>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525267934/d280681d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-267934</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-06.]]></description>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525259302/d41653d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-259302</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Major company event (8-K) on 2025-10-31.]]></description>
      <pubDate>Fri, 31 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525251874/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-251874</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-10-27.]]></description>
      <pubDate>Mon, 27 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000195004725008163/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-25-008163</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider sale notice (144) on 2025-10-24.]]></description>
      <pubDate>Fri, 24 Oct 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000138832525000011/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001388325-25-000011</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-10-20.]]></description>
      <pubDate>Mon, 20 Oct 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525243946/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-243946</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-10-20.]]></description>
      <pubDate>Mon, 20 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000201238325002576/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002012383-25-002576</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-10-17.]]></description>
      <pubDate>Fri, 17 Oct 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[FDMT: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000119312525238995/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-238995</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a Insider trade (4) on 2025-10-14.]]></description>
      <pubDate>Tue, 14 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[FDMT: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1650648/000095013025000195/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0000950130-25-000195</guid>
      <description><![CDATA[4D Molecular Therapeutics, Inc. filed a New insider ownership (3) on 2025-10-10.]]></description>
      <pubDate>Fri, 10 Oct 2025 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
  </channel>
</rss>